Wed.Apr 24, 2024

article thumbnail

Massive amounts of H5N1 vaccine would be needed if there’s a bird flu pandemic. Can we make enough?

STAT

The unsettling reality of H5N1 bird flu circulating in dairy cow herds in multiple parts of the United States is raising anxiety levels about whether this dangerous virus, which has haunted the sleep of people who worry about influenza pandemics for more than 20 years, could be on a path to acquiring the ability to easily infect people. To be clear, there is no evidence that this is currently the case — the sole confirmed human case reported in Texas three weeks ago was in a farm worker w

Vaccines 363
article thumbnail

Biogen: Don’t expect any big acquisitions this year

PharmaVoice

While the company is eager to diversify, CEO Chris Viehbacher said that in the near-term any dealmaking would likely focus on collaborations and early-stage assets.

148
148
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

USDA orders H5N1 testing of some dairy cows to limit spread of bird flu

STAT

The U.S. Department of Agriculture moved to try to limit spread of the H5N1 bird flu virus among dairy cattle on Wednesday, issuing a federal order that will require an animal to test negative for the virus before it can be moved across state lines. It also requires laboratories and state veterinarians to report to the USDA any animals that have tested positive for H5N1 or any other influenza A virus.

363
363
article thumbnail

AbbVie and Regenxbio’s ‘multibillion-dollar opportunity’ in vision loss gene therapy

PharmaVoice

After a successful mid-stage study, the companies aim to upend traditional wet AMD treatments with a one-time gene therapy.

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Decline in heart failure deaths has been undone, led by people under 45

STAT

Heart failure mortality rates are moving in the wrong direction, a new analysis reports, reversing a decline in deaths that means more people in the United States are dying of the condition today than 25 years ago. The concerning conclusion comes as newer medications are raising hopes for better outcomes in the years to come. A research letter published Wednesday in JAMA Cardiology tracked U.S. death certificate data from 1999 through 2021, revealing a steady drop in deaths until 2012, when rate

362
362
article thumbnail

Pfizer and BioNTech commence legal action against Moderna in UK court

Pharmaceutical Technology

Pfizer and its Germany partner BioNTech have urged London’s High Court to invalidate competitor Moderna's patents over technology instrumental in the Covid-19 vaccines development as the latest phase of a global legal fight that started yesterday (23 April), reported Reuters.

Vaccines 130

More Trending

article thumbnail

FDA initiative puts AR/VR at heart of home health drive

pharmaphorum

A new FDA initiative is seeing how augmented reality and virtual reality (AR/VR) can make patients’ own homes an integral part of the healthcare system

122
122
article thumbnail

STAT+: Equity, technology, and costs top of mind for life science’s leaders

STAT

Physicians, researchers, CEOs, reporters, and more gathered in downtown Boston Wednesday night to celebrate STAT’s 2024 STATUS List , which features 50 leaders in the life sciences. Members of this year’s list (and a few past honorees) spoke about what issues in their fields — ranging from investment to clinical research to bedside treatment — need to be prioritized in order to improve health care across the U.S. and the rest of the world.

article thumbnail

Emergence of ADCs as the “hot, new technology”

pharmaphorum

Explore the emergence of ADCs as the "hot, new technology" in the biopharmaceutical industry with companies like ImmunoGen, acquisitioned by AbbVie leading the way. Understand the potential of antibody-drug conjugates and their impact on innovative therapies.

115
115
article thumbnail

STAT+: New studies suggest GLP-1 health care costs have only begun to climb

STAT

Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they’re set to cost the U.S. health care system and the federal government still more this year and beyond, two new reports released Wednesday show. One study from the American Society of Health-System Pharmacists found that GLP-1 treatments were a main driver of the increase in overall drug spending by health entities such as pharmacies and hospitals last year.

Diabetes 347
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Embracing a new future-ready pharmacovigilance ecosystem

pharmaphorum

Explore the concept of embracing a future-ready pharmacovigilance ecosystem and discover how advancements in technology and regulations are shaping the future of drug safety monitoring.

115
115
article thumbnail

STAT+: HCA to expand the use of AI tool to automate clinical documentation in ER

STAT

HCA Healthcare, the largest for-profit hospital chain in the United States, is planning to expand the use of an artificial intelligence tool to document doctor-patient interactions in its emergency rooms. The plans for a broader roll out of the AI tool across its network comes nearly a year after the 184-hospital health system started working with medical documentation company Augmedix to pilot its ambient scribe technology at a handful of ER departments within the HCA network.

article thumbnail

Moderna turns to AI to change how its employees work

BioPharma Dive

An expanded partnership with OpenAI is helping Moderna embed custom-built AI chatbots in a wide range of research and business processes.

120
120
article thumbnail

Chocolate milk will stay on school lunch menus, as USDA reverses course

STAT

WASHINGTON – Chocolate milk in schools is here to stay. The Department of Agriculture announced Wednesday that it has abandoned a previous proposal to restrict the sale of flavored milk in elementary and middle schools. Instead, the USDA will enforce a limit on added sugars in flavored milk starting in the fall of 2025.

331
331
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

London ICB trialling retention scheme for practice pharmacists

The Pharmacist

North East London Integrated Care Board (ICB) has piloted a retention scheme for clinical pharmacists that offers them portfolio roles across general practice and specialist or academic work. In an interview with our sister title Healthcare Leader the ICB's chief executive Zina Etheridge said the area had particular issues with retention due to the difference […] The post London ICB trialling retention scheme for practice pharmacists appeared first on The Pharmacist.

102
102
article thumbnail

STAT+: Colombia issues a compulsory license for an HIV medicine and ‘plants a flag for global health equity’

STAT

After months of deliberation, the Colombian government has issued a compulsory license for an HIV medicine, the first time the country has taken such a step, one that also marks a significant move in the increasingly global battle over access to medicines. The license is designed so that tens of thousands of Colombians can obtain a lower-cost version of dolutegravir, a medicine that is manufactured and sold by ViiV Healthcare, a company that specializes in HIV treatments and is largely controlle

342
342
article thumbnail

Roche says it has shed 20% of NMEs from its pipeline

pharmaphorum

Roche chief executive Thomas Schinecker said today that one in five of the pharma division’s pipeline of new molecular entities (NMEs) has been culled in the last few months as part of a shift in focus on “high impact” projects.

104
104
article thumbnail

STAT+: Biosimilars haven’t always yielded lower out-of-pocket costs for patients, study finds

STAT

Two years after biosimilars became available in the U.S., a higher proportion of patients using brand-name biologics were paying out-of-pocket costs, which were also, on average, 12% higher than before, according to a recent study. In addition, patients who used biosimilars often did not pay lower out-of-pocket costs than those who were given brand-name biologic medicines.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Microbe-carrying particle recovery efficacy with manual surface sampling

European Pharmaceutical Review

Researchers have evaluated microbial contamination surface sampling methods to assess the recovery efficacy of naturally occurring microbe-carrying particles (MCPs). Sterile tryptone soya agar 55mm diameter tryptone soya agar RODAC contact plates were used in the investigation. Three different manual sampling methods were tested on contaminated hard surfaces containing MCPs dispersed from a person within heavily populated environments.

97
article thumbnail

Watch: What we know about traces of H5N1 bird flu found in pasteurized milk

STAT

Genetic evidence of the H5N1 bird flu virus was  found in grocery store milk in the United States this week, according to the Food and Drug Administration. The news follows the discovery that the avian flu has been detected in dairy cows. But what do traces of virus in pasteurized milk mean for consumers? In this video, STAT explains what is known about the safety of milk on grocery shelves.

article thumbnail

Karen Ooms' keen interest in Schrodinger's Cat and how it led to a 35-year career in science

Outsourcing Pharma

From a child's chemistry set given to her by her grandfather to watching Open University maths programs, Karen Ooms seemed destined for a career in science.

108
108
article thumbnail

STAT+: Biogen’s Alzheimer’s drug launch on ‘steady pace’ as logistical hurdles recede

STAT

Biogen on Wednesday reported first-quarter earnings that beat Wall Street expectations largely on reduced expenses. Total revenue was slightly weak overall, but sales were stronger for two newly launched medicines — Leqembi and Skyclarys — that matter most to the biotech’s turnaround effort. Shares rose 5% to $202 in early trading.

323
323
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Biogen to invest more in launch of Alzheimer’s drug Leqembi

BioPharma Dive

Growing demand has convinced Biogen that it's worth expanding the sales force around Leqembi by 30%.

124
124
article thumbnail

STAT+: A spending frenzy on obesity drugs

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning! Today we have some developments about Novo Nordisk’s insulin business, a side of the company that people don’t really talk about anymore, and some news about their GLP-1 business, a side that people can’t stop talking about.

Diabetes 299
article thumbnail

NICE recommends Novartis precision brain cancer treatment

European Pharmaceutical Review

in clinical trials [the combination treatment was shown] to halt tumour growth for low-grade gliomas for an average of more than two years” The National Institute for Health and Care Excellence (NICE) has recommended a new targeted drug combination treatment for young people with BRAF V600E mutation-positive glioma. Dabrafenib (Finlee) in combination with trametinib (Spexotras) is indicated for patients aged one and over, based on the agency’s proposal in its final draft guidance.

article thumbnail

STAT+: Takeda is fourth big company to leave BIO since December

STAT

WASHINGTON — Takeda Pharmaceuticals has left the biotechnology industry’s main lobbying group, the fourth departure of a major member since December, the company confirmed. “Takeda decided not to renew its membership with the Biotechnology Innovation Organization at the end of March 2024, aligned with the end of Takeda’s Fiscal Year,” a company spokesperson said.

280
280
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Enter Xaira, with $1bn for its AI in drug discovery platform

pharmaphorum

New biotech Xaira Therapeutics emerges with $1bn in funding for its plan to apply AI to drug discovery in ways hard to achieve with conventional technologies

101
101
article thumbnail

She was too sick for a traditional transplant. So she received a pig kidney and a heart pump

STAT

NEW YORK — Doctors have transplanted a pig kidney into a New Jersey woman who was near death, part of a dramatic pair of surgeries that also stabilized her failing heart. Lisa Pisano’s combination of heart and kidney failure left her too sick to qualify for a traditional transplant, and out of options. Then doctors at NYU Langone Health devised a novel one-two punch: Implant a mechanical pump to keep her heart beating and days later transplant a kidney from a genetically modified p

257
257
article thumbnail

NICE backs Novartis duo for NHS use in young glioma patients

pharmaphorum

An oral therapy that can allow children and adolescents with an aggressive form of brain cancer to be treated at home rather than in hospital has been recommended for use by the NHS in England and Wales.

article thumbnail

European Commission approves Astellas’ drug for expanded prostate cancer Treatment

Outsourcing Pharma

Today (April 24), Astellas Pharma Inc. revealed that XTANDITM (enzalutamide) has received a label extension from the European Commission, marking it as the inaugural and only novel hormone therapy endorsed for high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer (nmHSPC) treatment in the European Union (EU).

article thumbnail

Why healthcare is an easy target for cyberattacks

pharmaphorum

Explore why healthcare organisations are often targeted by cyberattacks and learn about the common vulnerabilities that make them susceptible to security breaches in this informative article.

95